NEW YORK, July 7, 2022 /PRNewswire/ — 5WPR, one of the largest independently-owned PR firms in the U.S., announced today the expansion of its Health and Wellness practice area with the creation of a specialty health supplements division. The division is made up of professionals across the health and wellness practice, working to elevate health supplement, vitamin, and CBD wellness clients.
5WPR is a recognized leader in the health and wellness industry, possessing unrivaled expertise in consumer health. The health supplements division will combine experts from the health and wellness team, leadership experts from the CBD, THC and cannabis PR team, as well as insights from members of the consumer packaged goods team.
“5W possesses a deep understanding and a wealth of experience when it comes to building and implementing programs that provide incredible value and drive real business for our health and wellness brands,” said 5WPR CEO, Dara A. Busch. “There are many intricacies working alongside health supplement providers, from building messaging around the many benefits of the supplements, to highlighting ingredients and understanding regulations. We understand there is no one-size-fits-all approach when it comes to health and wellness, especially with supplements, and we look forward to providing more tailored service to health supplement brands.”
A 2022 report released by ADM (Chicago) found 79% of U.S. consumers say that taking supplements is important to their overall health, with 75% of U.S. dietary supplement users looking for personalized products directly suited to their needs.
PR services offered to health supplement clients include messaging and positioning, media relations, influencer relations, product launches, new market expansion campaigns, executive visibility programs, fundraising announcements, content creation, sponsorships/partnerships, digital media campaigns, thought leadership and speaking opportunities.
About 5WPR
5W Public Relations is a full-service PR agency in NYC known for cutting-edge programs that engage with businesses, issues and ideas. With more than 275 professionals serving clients in B2C (Beauty & Fashion, Consumer Brands, Entertainment, Food & Beverage, Health & Wellness, Travel & Hospitality, Technology, Nonprofit), B2B (Corporate Communications and Reputation Management), Public Affairs, Crisis Communications and Digital Marketing (Social Media, Influencer, Paid Media, SEO). 5W was named to Inc. Magazine’s Best Workplaces 2022 list, awarded 2020 PR Agency of The Year, and brings leading businesses a resourceful, bold and results-driven approach to communication.
Media Contact
Dara A. Busch
[email protected] / 212.999.5585
View original content to download multimedia:https://www.prnewswire.com/news-releases/5wpr-announces-expansion-of-health-and-wellness-practice-with-specialty-health-supplements-division-301582335.html
SOURCE 5W Public Relations
At Illumina, we are driven by the power of genomics to positively impact the world and shape a more sustainable and equitable future for all.
AbbVie Inc (NYSE: ABBV) has decided to terminate the CD33 collaboration program with Alector Inc (NASDAQ: ALEC), developing AL003 for Alzheimer’s disease as one of two programs under the co-development and option agreement. As previously disclosed, Alector was reviewing the next steps for the AL003 program. In November last year, Alector presented Phase 1 AL003 data at the annual Clinical Trials on Alzheimer’s Disease conference. The data provided early evidence that the candidate is well tolera
The U.S. Food and Drug Administration said on Friday it has granted full approval to Pfizer and BioNTech's COVID-19 vaccine for adolescents aged between 12 and 15 years. The vaccine, sold under the brand name Comirnaty for adults, has been available under an emergency use authorization since May 2021 for the 12-15 age group. The FDA said on Friday the full approval follows a rigorous analysis and evaluation of the safety and effectiveness data.
List of omicron symptoms: Omicron BA.4 and BA.5 may have different symptoms than previous Covid strains. What to look out for.
Less than eight weeks ago, the Florida Department of Health reported the state’s first presumptive case of monkeypox — a viral disease that was once rare in the United States.
The job cuts will save the company more than $15 million annually, it said, with upfront restructuring costs of $4.2 million.
"There does come a point when you've taken it too far — overfilled, too tight, too much cosmetic work. There's nothing worse," the SKIMS founder told Allure.
The FDA has given priority review to lecanemab, the second Alzheimer's disease drug made by Biogen and Japanese pharmaceutical firm Eisai, under the accelerated approval pathway — the same regulatory route used by the companies for Aduhelm.
Although fears may be growing that another COVID-19 surge will be upon us in the coming months, there is some indication that the future is now.
CytomX Therapeutics Inc's (NASDAQ: CTMX) Phase 2 study of praluzatamab ravtansine in hormone receptor-positive (HR+)/human epidermal growth factor receptor 2 (HER2)-non-amplified breast cancer (Arm A) met its primary efficacy endpoint of confirmed objective response rate (ORR) of more than 10%. As of the data cutoff on May 13, 47 patients unselected for CD166 expression with advanced HR+/HER2-non-amplified breast cancer were evaluable for the primary efficacy endpoint. The ORR was 15% in 47 eval
Vertex Pharmaceuticals Incorporated (Canada) (Nasdaq: VRTX) today announced that it has signed a Letter of Intent (LOI) with the pan-Canadian Pharmaceutical Alliance (pCPA), which represents an agreement in principle regarding the public reimbursement of PrTRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) for patients ages 6 years and older who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
WASHINGTON (Reuters) -U.S. President Joe Biden said the Supreme Court decision overturning the right to an abortion was an exercise in "raw political power" and signed an executive order on Friday to ease access to services to terminate pregnancies. Biden, a Democrat, has been under pressure from his own party to take action after the landmark decision last month to overturn Roe v Wade, which upended roughly 50 years of protections for women's reproductive rights. The order directs the government's health department to expand access to "medication abortion" – pills prescribed to end pregnancies – and ensure women have access to emergency medical care, family planning services and contraception.
With just a very small amount of raw sewage and a new analysis technique, researchers can determine the genetic mixture of SARS-CoV-2 variants in the community and detect new variants up to 14 days before they start showing up on patients' nasal swabs, according to a new report. Until recently, levels of SARS-CoV-2 genetic material in wastewater could help track the distribution and transmission of infections but did not yield information about individual variants. Tests of a new method for wastewater genomic surveillance at the University of California, San Diego campus from November 2020 to September 2021 detected the Epsilon, Alpha and Delta variants "earlier and more consistently than clinical samples, and identified multiple instances of virus spread" that were not detected with traditional monitoring, researchers reported on Thursday in Nature.
The new action expands the full approval of the vaccine, which has been available to 12- to 15-year-olds since May 2021 on an emergency basis.
Democratic proposal to force someone who causes a pregnancy to pay for unintended ones got a boost from an unexpected source: Christian lobbyists.
Bausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb"), a leading global eye health company dedicated to helping people see better to live better, and Novaliq GmbH, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics, today announced the submission of a New Drug Application (NDA) at the end of June to the U.S. Food and Drug Administration (FDA) seeking approval for NOV03 (perfluorohexyloctane), an investigational treatment with a proposed indication of trea
While the daily averages of new COVID-19 cases and deaths remained in relatively tight ranges, hospitalizations jumped to a four-month high, and the positivity rate of tests climbed to a five-month high, as the omicron subvariant BA.5 continued to spread.
When Florida passed a law this spring that bans most abortions after 15 weeks of pregnancy, Rabbi Barry Silver was furious. Silver’s progressive synagogue, Congregation L’Dor Va-Dor in Palm Beach County, sued the state of Florida in June, arguing that the anti-abortion law infringes on religious liberty. Judaism has viewed abortion as morally acceptable—and even required in some circumstances—for thousands of years.
Photo Illustration by Thomas Levinson/The Daily Beast/GettyThe latest subvariant of the novel coronavirus to become dominant in Europe, the United States, and other places is also, in many ways, the worst so far.The BA.5 subvariant of the basic Omicron variant appears to be more contagious than any previous form of the virus. It’s apparently better at dodging our antibodies, too—meaning it might be more likely to cause breakthrough and repeat infections.Vaccines and boosters are still the best d
Vowing to continue the fight against last month’s Supreme Court overruling of the 1973 decision in Roe v. Wade that made abortion legal nationwide, President Biden signed an executive order on Friday that would push back against Republican efforts to limit reproductive choice.

source